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Indigenous Australian children with acute otitis
media with perforation supports a role for
Alloiococcus otitidis as a secondary pathogen
Robyn L Marsh1,2*, Michael J Binks1,2, Jemima Beissbarth1,2, Peter Christensen1,2, Peter S Morris1,2,3,
Amanda J Leach1,2 and Heidi C Smith-Vaughan1,2Abstract
Background: Otitis media is endemic in remote Indigenous communities of Australia’s Northern Territory.
Alloiococcus otitidis is an outer ear commensal and putative middle ear pathogen that has not previously been
described in acute otitis media (AOM) in this population. The aims of this study were to determine the presence,
antibiotic susceptibility and bacterial load of A. otitidis in nasopharyngeal and ear discharge swabs collected
from Indigenous Australian children with AOM with perforation.
Methods: Paired nasopharyngeal and ear discharge swabs from 27 children with AOM with perforation were tested
by A. otitidis quantitative PCR (qPCR). Positive swabs were cultured for 21 days. Total and respiratory pathogen
bacterial loads in A. otitidis-positive swabs were determined by qPCR.
Results: A. otitidis was detected by qPCR in 11 ear discharge swabs from 10 of 27 (37%) children, but was
not detected in paired nasopharyngeal swabs. A. otitidis was cultured from 5 of 11 qPCR-positive swabs from
four children. All A. otitidis isolates had minimum inhibitory concentrations consistent with macrolide resistance.
All A. otitidis qPCR-positive swabs were culture-positive for other bacteria. A. otitidis bacterial load ranged from
2.2 × 104-1.1 × 108 cells/swab (median 1.8 × 105 cells/swab). The relative abundance of A. otitidis ranged from 0.01%
to 34% of the total bacterial load (median 0.7%). In 6 of 11 qPCR-positive swabs the A. otitidis relative abundance
was <1% and in 5 of 11 it was between 2% and 34%. The A. otitidis bacterial load and relative abundance
measures were comparable to that of Haemophilus influenzae.
Conclusions: A. otitidis can be a dominant species in the bacterial communities present in the ear discharge of
Indigenous children with AOM with perforation. The absence of A. otitidis in nasopharyngeal swabs suggests the
ear canal as the likely primary reservoir. The significance of A. otitidis at low relative abundance is unclear; however,
at higher relative abundance it may be contributing to the associated inflammation. Further studies to better
understand A. otitidis as a secondary otopathogen are warranted, particularly in populations at high-risk of
progression to chronic suppurative otitis media and where macrolide therapies are being used.
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Otitis media is endemic in remote Indigenous communi-
ties in Australia’s Northern Territory. In this population,
middle ear infection begins in the first weeks and
months of life [1] and often progresses to perforation
and chronic suppurative otitis media (CSOM) [2].
Cross-sectional studies have reported perforation in up
to 24% of Indigenous children in the Northern Territory
[3], exceeding the rate of 4% recommended by the
World Health Organization as requiring urgent public
health attention [4]. Standard antibiotic therapies for
acute otitis media (AOM) have limited effect in this
population. A randomised controlled trial (RCT) of anti-
biotic treatments for AOM in Indigenous children
reported clinical treatment failure in 50% and 54% of
children treated with single dose azithromycin or 7 days
amoxycillin, respectively (RD, -4%, [95% CI, -15% to 7%];
P = 0.504) [5]. High clinical failure rates following anti-
biotic treatment are likely due to the dense, polymicro-
bial nature of otitis media in this population [6].
Alloiococcus otitidis is a slow-growing, strictly aerobic,
Gram-positive coccus [7]. Culture-based detection of
this species requires prolonged incubation for 5-14 days
in an aerobic environment [8-10], and thus, A. otitidis
will not be detected by the standard culture conditions
used to identify Streptococcus pneumoniae or Haemo-
philus influenzae.
A. otitidis has not previously been considered in AOM
affecting Indigenous Australian children; although one
Australian study reported 45% Indigenous children with
otitis media with effusion (OME) had A. otitidis-culture
positive middle ear specimens [8]. Qualitative PCR-
based studies from other populations have reported
A. otitidis in MEF collected by tympanocentesis from
20-61% of children with chronic OME [11-14] and 25-
50% of children with AOM [13,15-17].
Despite its detection in middle ear fluid (MEF), a pri-
mary pathogenic role for A. otitidis remains controver-
sial. Data supporting a pathogenic role for A. otitidis
include its detection in MEF from children with OME
[14,16,18] and AOM [17] (in the absence of recognised
otopathogens), and its capacity to provoke an inflamma-
tory response [18-21]. One study of children with AOM
reported IL-8, IL-1-β and IL-6 levels in A. otitidis-posi-
tive MEF to be similar to that of S. pneumoniae-positive
specimens [22].
The reservoir of A. otitidis associated with otitis media
is unclear. A. otitidis has been detected by culture or
PCR in 7-12% of nasopharyngeal swabs from paediatric
and adult patients with upper respiratory infection or
otitis media [9,16,23]. It has also been detected by cul-
ture or PCR in 14-83% of ear canal swabs from healthy
volunteers [9,24-26], suggesting A. otitidis detection in
MEF may reflect specimen contamination by normalcanal flora. However, both PCR and culture-based stud-
ies have reported A. otitidis in MEF collected by tympa-
nocentesis after careful cleaning and disinfection of the
canal and tympanic membrane [8,14,22,27].
Although A. otitidis antibiotic minimum inhibitory
concentration (MIC) breakpoints have not been def-
ined [28], MIC levels consistent with macrolide resist-
ance in S. pneumoniae have been reported for 11 of
20 (55%) [8] and 11 of 12 (92%) [29] A. otitidis isolates
from two studies.
Azithromycin is an emerging AOM therapy for Indi-
genous Australian children [5]. Whether A. otitidis is
associated with AOM in this population (and the signifi-
cance of any association) is currently unclear. The aims
of this study were: i) to determine the prevalence of
A. otitidis in nasopharyngeal and ear discharge swabs
from Indigenous Australian children with AOM with
perforation; ii) to determine the antibiotic susceptibility
of A. otitidis isolates to penicillin and macrolides;
and iii) to determine the relative abundance of A. otitidis
in polymicrobial specimens.
Methods
Ethical approval
Ethical approval for this study (HREC 07/85) was pro-
vided by the Human Research Ethics Committee of the
Northern Territory Department of Health and Menzies
School of Health Research, which includes an Aboriginal
Sub-committee.
Otitis media definitions
Otitis media definitions were as previously described [5].
AOM with perforation was defined as the presence
of middle ear discharge for less than six weeks, and
perforation covering less than 2% of the pars tensa of
the tympanic membrane. Acute otitis media without
perforation was defined as a bulging tympanic mem-
brane and a type B tympanogram. OME was defined
as an intact and non-bulging tympanic membrane and
type B tympanogram.
Specimens
This study retrospectively tested paired nasopharyngeal
and ear discharge swabs collected at enrolment into a
randomised controlled trial (RCT) of amoxycillin or azi-
thromycin treatment for acute otitis media, conducted
between March 2003 and July 2005 [5]. Eligible children
were Indigenous, living in a remote community, between
6 months and 6 years of age, and had not received anti-
biotics in the 7 days preceding specimen collection [5].
Children were only selected for inclusion in the A. otiti-
dis study if parental consent was given for their future
use in related studies.
Marsh et al. BMC Ear, Nose and Throat Disorders 2012, 12:11 Page 3 of 10
http://www.biomedcentral.com/1472-6815/12/11The RCT enrolled 320 children and included 49 chil-
dren with a diagnosis of AOM with perforation. Of these
49 children, paired baseline nasopharyngeal and ear dis-
charge swabs from 27 Indigenous children (median age
1.2 years, range 0.5-4.0 years) with AOM with perfor-
ation were available for A. otitidis testing. Four children
had bilateral perforation. Thus, the sample set included
27 nasopharyngeal and 31 ear discharge swabs (58 swabs
in total). As part of the original RCT, 12 children were
treated with amoxycillin (50mg/kg/day in two divided
doses for a minimum of 7 days) and 15 received azithro-
mycin (30mg/kg as a single dose). Tympanic membrane
perforation had not resolved in 21 of 27 children when
reviewed 6-11 days after antibiotic treatment com-
menced. In the six remaining children, 3 had AOM
without perforation (2 azithromycin treated) and 3 had
OME (2 azithromycin treated) when reviewed.
Nasopharyngeal swabs were collected as previously
described [5,30]. Ear discharge swabs were collected after
the ear canal was cleaned to remove any visible debris
and pus. The ear discharge was then sampled under dir-
ect vision (Welch Allyn Lumiview) by positioning the
swab as close to the perforation as possible. Swabs were
placed in 1mL skim milk-tryptone-glucose-glycerol broth
[31] and frozen immediately at -20°C before being trans-
ported to the laboratory in a liquid nitrogen dry shipper
[30] for long-term at storage -70°C.
DNA extraction
Total DNA was extracted from the swabs as previously
described [6] with some modification. Briefly, cellular
material in a 200μL aliquot of each swab was pelleted by
centrifugation. Pellets were resuspended with 200μL of
enzymatic lysis buffer (containing 36.25mM phosphate
buffer, 1mg/mL lysozyme (SigmaW), 0.75mg/mL mutano-
lysin (SigmaW), and 2mg/mL Proteinase K(QIAGEN))
then incubated at 56°C for 45 min. 10μL of 20% w/v
sodium dodecyl sulfate (Amresco) was added, followed
by gentle mixing at room temperature for 2 min. If the
solution did not become clear, 20μL of 20mg/mL Pro-
teinase K was added and the samples were incubated at
56°C for 10 min. 4μL of 100μg/mL RNase A (QIAGEN)
was added and the samples were incubated at 70°C for
10 min. 200μL of 100% ethanol (Merck) was added and
the samples were pulse vortexed for 15 s. DNA was then
extracted using QIAamp DNA Mini Kit (QIAGEN) as
per the manufacturer’s tissue protocol. DNA was eluted
with 200μL of Buffer AE (QIAGEN).
For bacterial isolates, up to 100 colonies were har-
vested from purity plates and suspended in sterile water.
Cells were pelleted by centrifugation and DNA was
extracted as described above. The DNA concentration
was determined using PicoGreenW reagent (Molecular
Probes) as per the manufacturer’s instructions withfluorescence measured using a Victor3TM 1420 Multi-
label counter (Perkin Elmer) and WorkOut software
(Perkin Elmer; version 2.5).
General parameters for bacterial load qPCR assays
All qPCR assays were performed using Rotor-Gene 6000
real-time thermocyclers (Corbett Research). Quantitative
standards were prepared by 1:10 serial dilution of refer-
ence isolate genomic DNA. qPCR raw data and standard
curves were prepared using the Rotor-Gene 6000 soft-
ware (Corbett Research; version 1.7). All standard curves
were linear within the ranges described below. The
qPCR efficiency and R2 values were calculated using the
“Auto-find threshold” function with default settings. All
standards and samples were tested in duplicate. Results
were only accepted where duplicates differed by ≤0.5
cycles. Each assay’s limit of detection was defined as the
lowest standard concentration at which specific amplifi-
cation was detected in at least 95% of replicates [32].
A. otitidis qPCR
The A. otitidis qPCR used primers previously described
by Hendolin et al. [33] (Table 1) which amplify a 265-bp
A. otitidis-specific region of the 16S rRNA gene [Gen-
Bank: NR_026088] between positions 437-702, based on
E. coli numbering. The qPCR was done using a Sensi-
MixTM NoRef Kit (Bioline). Each 10μL qPCR included
1μM of each primer, 1X SensiMixTM NoRef reagent,
0.5X SYBRW Green I solution (Bioline), and 1μL tem-
plate DNA. The reaction conditions were 95°C for
10 min followed by 35 cycles of 95°C for 15 s, 66°C for
30 s and 72°C for 15 s; then a final extension at 72°C
for 1 min. This was followed by 50°C for 2 min before
melt-curve analysis from 80°C-90°C in 1°C steps. Agarose
gel electrophoresis was done to confirm amplification of
the expected 265-bp product.
The standard curve (100pg-100fg) was prepared using
genomic DNA from the A. otitidis reference isolate
ATCC51267. The limit of detection was 100fg of gen-
omic DNA, which is equivalent to ~50 genome copies
based on an A. otitidis genome size of ~1.7-Mb [34].
The A. otitidis qPCR efficiency ranged from 0.87-0.90
and all standard curves had R2 values >0.99. The no
template control was negative in all except two instances
in which non-specific amplification was detected below
the assay’s limit of detection – quantification cycle (Cq)
32-33 which was at least 5 cycles beyond the limit of
detection, at a concentration less than one cell, suggest-
ing detection of primer-dimers.
For swabs, positive results were defined as Cq-value
less than or equal to that of the 100fg standard with a
dissociation temperature (as determined by melt-curve
analysis) within 0.5°C of the mean dissociation tempe-
rature of the assay’s standards. Negative results were
Table 1 Primers and probes used in qPCR assays
Assay Gene Primer and Probe sequences Position Amplicon
size (bp)
Reference
Ao 16S rRNA Forward primer 5'- CTACGCATTTCACCGCTACAC -3' 437-457 265 [33]
Reverse primer 5'- GGGGAAGAACACGGATAGGA -3' 702-483
TBL 16S rRNA Forward primer 5'- TCCTACGGGAGGCAGCAGT -3' 331-349 466 [6,36]
Reverse primer 5'- GGACTACCAGGGTATCTAATCCTGTT -3' 797-772
Hi hpd Forward primer 5’- GGTTAAATATGCCGATGGTGTTG -3’ 822-844 151 [37,38]
Reverse primer 5’- TGCATCTTTACGCACGGTGTA -3’ 972-953
Probe 5’Hex- TTGTGTACACTCCGT “T” GGTAAAAGAACTTGCAC -SpC6 -3’* 928-896
Spn lytA Forward primer 5'- TCTTACGCAATCTAGCAGATGAAGC -3' 306-326 101 [6]
Reverse primer 5'- GTTGTTTGGTTGGTTATTCGTGC -3' 406-386
Probe 5'- [6-FAM]-TTTGCCGAAAACGCTTGATACAGGG -[TAMRA] -3' 354-330
Mc copB Forward primer 5'- GTGAGTGCCGCTTTTACAACC -3' 50-70 72 [6]
Reverse primer 5'- TGTATCGCCTGCCAAGACAA -3' 121-102
Ao=A. otitidis. TBL = Total bacterial load. Spn = S. pneumoniae. Hi =H. influenzae. Mc =M. catarrhalis. 16S rRNA gene position numbers are based on E. coli
numbering. * Inverted commas in the primer sequence of the hpd probe indicate the position of the Black Hole Quencher.
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lification but dissociation temperature >0.5°C different
to the mean dissociation temperature of the standards,
consistent with primer-dimer or other non-specific ampli-
cons. Results were considered equivocal when i) replicates
gave a positive and a negative result; or ii) Cq-values were
greater than that of the 100fg control but melt profiles
were consistent with A. otitidis, suggesting detection of
<50 cells. Equivocal PCRs were repeated with 2μL tem-
plate DNA. Samples that remained equivocal upon repeat
testing were recorded as A. otitidis negative.
Other bacterial load qPCR assays
H. influenzae, S. pneumoniae, M. catarrhalis and total
bacterial loads were estimated as previously described
[6,35,38] with modification as described in Additional
file 1. Primers and probes for all assays are shown in
Table 1.
A. otitidis culture and identification
Swabs qPCR-positive for A. otitidis were thawed on ice
and vortexed. 10μL was then inoculated onto horse
blood agar (Oxoid), and brain-heart-infusion agar (BHI;
Oxoid) supplemented with 6.5% NaCl (Crown Scien-
tific). Horse blood agar was selected as it had previously
been used to culture A. otitidis from middle ear speci-
mens [8]. As A. otitidis is salt tolerant [7], BHI agar with
6.5% NaCl was included as a potentially selective
medium, as previously proposed by Tano et al. [9].
A. otitidis reference strain ATCC51267 was used as a
positive control. Plates were incubated at 37°C in an am-
bient atmosphere and were read after 2, 5, 7, 9, 14 and
21 days of incubation. Small, off-white colonies [8] of
similar appearance to the A. otitidis reference isolate
were Gram stained and subcultured on horse bloodagar with incubation at 37°C for 48 hrs in an ambient
atmosphere. Alpha-haemolytic, catalase-positive, oxidase-
negative, Gram-positive cocci were considered presump-
tive A. otitidis [7]. Genomic DNA from presumptive
A. otitidis colonies was extracted and identification was
confirmed using the qPCR described above.
A. otitidis antibiotic susceptibility testing
Penicillin, erythromycin and azithromycin MICs were
determined using E-TestsW as previously described [8].
Briefly, isolates were suspended in sterile saline to no. 3
MacFarland standard then inoculated onto horse blood
agar plates. After drying, E-testW strips were applied and
the plates incubated at 37°C in an ambient atmosphere
for 48 hrs. These conditions are required to support suf-
ficient A. otitidis growth to enable MIC determination
[8]. As CLSI MIC breakpoints have not been determined
for A. otitidis, the breakpoints of S. pneumoniae [28]
were applied (consistent with previous studies [8,29]).
Culture for other bacterial species
Culture data for other bacterial species in A. otitidis
qPCR-positive swabs were derived from the original
RCT database. Culture had been performed as previ-
ously described [5,30] for 18-24 hrs and did not include
testing for A. otitidis.
Results
qPCR detection of A. otitidis
A. otitidis was detected by qPCR in ear discharge swabs
from 10 of 27 children (37%), including one child with
bilateral detection (11 positive ear discharge swabs in
total). In the remaining three children with bilateral per-
foration, two were qPCR-positive for A. otitidis in one
ear only; and one was A. otitidis negative. As part of the
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were treated with azithromycin and five treated with
amoxycillin. When reviewed 6-11 days after treatment,
7 of the 10 A. otitidis-positive children continued to
have a diagnosis of acute otitis media with perforation
(3 azithromycin treated, 4 amoxycillin treated). A. otitidis
was not detected by qPCR in nasopharyngeal swabs
(0/27). No further testing of nasopharyngeal swabs
was performed.
Culture of A. otitidis qPCR-positive swabs
A. otitidis was isolated from 5/11 qPCR-positive ear dis-
charge swabs from 4 children after 2-14 days’ incubation
(Table 2). As A. otitidis is salt tolerant [7], BHI agar with
6.5% NaCl was used as a selective medium [9]; however,
all cultures grew other bacterial species after two days’
incubation, resulting in substantial overgrowth before
day 21.
Susceptibility of A. otitidis isolates
Five A. otitidis isolates were available for antibiotic sus-
ceptibility testing (Table 2). Erythromycin MICs ranged
from 3 - >256μg/mL. Azithromycin MICs ranged from
1.5 - >256μg/mL. Penicillin MICs ranged from 0.006-
0.19μg/mL. If S. pneumoniae Clinical Laboratory Stan-
dards Institute (CLSI) MIC breakpoints [28] are applied,
as previously described [8,29], all isolates were resistant
to erythromycin and 4/5 were resistant to azithromycin.
Using S. pneumoniae CLSI breakpoints for oral penicillin
V, 3/5 isolates had intermediate penicillin susceptibility.
Other bacteria cultured from A. otitidis-positive ear
discharge swabs
Previously recorded culture data for the 11 A. otitidis
qPCR-positive swabs were reviewed to determine if
other species were present. All A. otitidis-qPCR positive
swabs were polymicrobial with at least 2-5 other species
cultured (Table 3). In one child (Child G), A. otitidis,
S. pneumoniae, H. influenzae, M. catarrhalis, Staphylo-
coccus sp. and other unidentified bacteria were allTable 2 A. otitidis isolates cultured from ear discharge swabs
Sample Days of culture until A. otitidis was isolated
HBA agar BHI agar with 6.5% NaCl
Child A (Left ear) 5 7
Child A (Right ear) 2 5
Child B 14 5
Child C Not detected* 9
Child D 7 Not detected
Culture and antibiotic susceptibility data for five isolates from four children (design
incubation. MIC values are in μg/mL. In the absence of A. otitidis-specific CLSI break
applied [28]. For oral penicillin V: sensitive ≤0.06μg/mL, intermediate susceptibility 0
intermediate susceptibility 0.5μg/mL, resistant ≥1μg/mL. For azithromycin: sensitive
HBA=Horse blood agar. *This plate was overgrown by a Proteus sp.detected. Overall, Staphylococcus sp. were cultured from
10 of the 11 A. otitidis qPCR-positive swabs.
A. otitidis bacterial load and relative abundance in
polymicrobial ear discharge specimens
As all A. otitidis-qPCR positive swabs were culture-
positive for at least two other species, bacterial load
measures were used to determine if A. otitidis was a
minor or dominant constituent of the bacterial commu-
nities (Table 4). A. otitidis bacterial load in the 11 qPCR-
positive swabs ranged from 2.2 × 104-1.1 × 108 cells/swab
(median 1.8 × 105 cells/swab), while the total bacterial
load estimates ranged from 1.5 × 107-8.1 × 108 cells/swab
(median 9.4 × 107 cells/swab; Figure 1).
A. otitidis relative abundance was then determined by
expressing its bacterial load as a percentage of the total
bacterial load (Table 4). The relative abundance of A. oti-
tidis ranged from 0.01-34% of the total bacterial load
(median 0.7%). In 6 of 11 qPCR-positive swabs the A.
otitidis relative abundance was <1% (median 0.2%). The
A. otitidis bacterial load in these swabs ranged from
2.2 × 104-1.8 × 105 cells/swab and only one swab was
positive by culture. In the remaining five swabs the rela-
tive abundance ranged from 2-34% of the total bacterial
load (median 9%). These samples had the highest A. oti-
tidis bacterial loads (2.9 × 106-1.1 × 108 cells/swab) and 4
of 5 were A. otitidis-positive by culture.
Bacterial load and relative abundance of A. otitidis
compared to recognised otopathogens
H. influenzae, S. pneumoniae and M. catarrhalis bacter-
ial loads were determined for the 11 A. otitidis-positive
ear discharge swabs (Table 4 and Figure 1). Ten A. otiti-
dis-positive swabs were also qPCR-positive for H. influ-
enzae. Overall, H. influenzae and A. otitidis bacterial
loads and relative abundances were similar (Table 4): the
bacterial load ranged from 4.3 × 104-1.2 × 107 cells/swab
for H. influenzae (median 7.4 × 105 cells/swab) and
2.2 × 104-1.1 × 108 cells/swab for A. otitidis (median
1.8 × 105 cells/swab). Maximum relative abundance wasPenicillin MIC Erythromycin MIC Azithromycin MIC
0.19 4 1.5
0.125 3 2
0.006 >256 128
0.19 >256 >256
0.032 96 64
ated child A-D). All cultures were positive for other bacteria after two days’
points, the MIC values used to define pneumococcal susceptibility were
.12-1μg/mL, resistant ≥2μg/mL. For erythromycin: sensitive ≤0.25μg/mL,
≤0.5μg/mL, intermediate susceptibility 1μg/mL, resistant ≥2μg/mL.
Table 3 Other bacteria previously cultured from A. otitidis qPCR-positive ear discharge specimens
Swab S. pneumoniae H. influenzae M. catarrhalis β-haemolytic
streptococci
Staphylococcus sp. P. aeruginosa Proteus sp. Other
Child A (Left ear) - + - - - - - +
Child A (Right ear) - + - - + - - -
Child B - - n/a - + n/a + +
Child C - - n/a - + - + +
Child D - - - + + - - +
Child E + + - - + - - -
Child F - - n/a - + n/a + +
Child G + + + - + - - +
Child H - - - - + - - +
Child I - - - - + + - +
Child J - - - - + + - +
These data were derived from the original RCT database. Culture data for M. catarrhalis and P. aeruginosa were not available for some swabs due to overgrowth
by Proteus species (n/a = not available).
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relative abundance of H. influenzae was <1% in 5/10 H.
influenzae qPCR-positive swabs. In 5/10 H. influenzae
qPCR-positive swabs the A. otitidis bacterial load was
higher than that of H. influenzae.
S. pneumoniae and M. catarrhalis were detected by
qPCR in fewer A. otitidis-positive swabs (3/11 and 4/11,
respectively) and were only present at <1% relative abun-
dance (Table 4). S. pneumoniae bacterial load ranged
from 3.5 × 104-1.8 × 105 cells/swab. M. catarrhalis bac-
terial load ranged from 4.3 × 104-5.9 × 105 cells/swab.
Discussion
A. otitidis is present in the ear discharge of Indigenous
children with AOM with perforation
In this study, A. otitidis was detected by qPCR in ear
discharge swabs from 10 of 27 children (37%). This rate
is consistent with PCR-based AOM studies from Fin-
land, the USA and Japan (25%, 32% and 50%, respect-
ively) [13,15,16], and a culture-based study of chronic
OME in Indigenous and non-Indigenous AustralianTable 4 H. influenzae, S. pneumoniae, and M. catarrhalis bacte
A.
In A. otitidis-positive ED swabs (n = 11#)
qPCR-positive swabs 11
Culture-positive swabs 5
Bacterial load range (cells/swab) 2.2
Number of swabs with bacterial load >1x106 cells/swab 5
Number of swabs culture-positive and bacterial load >1x106 cells/swab 4
Number of swabs with relative abundance <1% 6
Relative abundance range (%) 0.0
Number of swabs with relative abundance >1% 5
Relative abundance range (%) 2-3
#One child with bilateral. *A. otitidis culture was only performed for qPCR-positive schildren (45% and 36%, respectively) [8] which tested
MEF from children referred for myringotomy.
A. otitidis isolation from ear discharge swabs
Published incubation times for A. otitidis culture vary
from 5-14 days [9,22]. Data from this study support cul-
ture for 14 days. It is important to note that unless
extended incubation times are used, culture-based otitis
media studies may not detect A. otitidis.
Using an extended culture procedure, we isolated
A. otitidis from 5 of 11 qPCR-positive ear discharge
swabs. Several factors may have contributed to the
low A. otitidis isolation rate. Firstly, PCR-positive but
culture-negative results may indicate detection of non-
viable bacteria; however, it is generally accepted that
DNA is quickly cleared from the middle ear [39-41] sug-
gesting that a positive PCR is indicative of viable cells.
Secondly, A. otitidis viability may have been affected by
storage at -70°C for up to five years; however, viability
of S. pneumoniae and H. influenzae has been demon-
strated in swabs stored for up to 12 years at -70°C [42]rial loads in A. otitidis-positive ear discharge swabs
otitidis H. influenzae S. pneumoniae M. catarrhalis
10 3 4
4 2 1
× 104-1.1 ×108 4.3 ×104-1.2 ×107 3.5 ×104-1.8 ×105 4.3 ×104-5.9 ×105
5 0 0
3 0 0
5 3 4
1-0.70 0.02-0.79 0.01-0.68 0.01-0.89
5 0 0
4 4-27 0 0
wabs.
Figure 1 Total and species-specific bacterial loads in 11 A.
otitidis-positive ear discharge swabs. Species-specific data points
are only shown for qPCR-positive specimens. A. otitidis, H. influenzae
and total bacterial load median values are indicated with a bar.
TBL = Total bacterial load. Ao= A. otitidis. Hi =H. influenzae.
Spn = S. pneumoniae. Mc =M. catarrhalis.
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prolonged storage.
Overgrowth by other bacterial species likely affected
A. otitidis isolation. All cultures grew other species after
two days’ incubation, which potentially obscured the
small A. otitidis colonies. Use of BHI agar with 6.5%
NaCl as a selective medium was unsuccessful due to
heavy overgrowth by other species after two days’ incu-
bation, despite the high salt concentration. Interestingly,
successful A. otitidis culture was associated with higher
bacterial loads (4 of 5 culture-positive swabs with bacter-
ial load ≥1 × 106cells/swab versus 1/6 culture-positive
with bacterial load <1 × 106cells/swab). The small study
size limits further interpretation of this finding. Overall,
our findings are consistent with the lower sensitivity of
culture compared to PCR that has been documented for
several bacteria in middle ear samples [43] and high-
lights the difficulties associated with A. otitidis culture,
even when prolonged culture conditions are used.
Macrolide resistance in A. otitidis isolates
The five A. otitidis isolates had MIC values suggestive of
macrolide resistance (erythromycin MICs 3 to >256μg/
mL; azithromycin MICs 1.5 to >256μg/mL). If S. pneu-
moniae CLSI breakpoints are applied [8,29], 3 of 5
A. otitidis isolates also had intermediate level penicillin
resistance. The validity of applying S. pneumoniae break-
points to interpret A. otitidis MIC data remains to be
determined, especially as atypical culture conditions are
required to achieve sufficient growth [8]. Specific CLSI
breakpoints are required to confirm macrolide resistance
and reduced-penicillin susceptibility in A. otitidis iso-
lates. Overall, our findings are consistent with previous
studies describing macrolide resistance in A. otitidis
[8,29].Is A. otitidis contributing to middle ear pathology?
The clinical significance of A. otitidis in the ear dis-
charge swabs is unclear. Several studies have found
A. otitidis in the ear canal of healthy volunteers indicat-
ing that it is part of the normal canal flora [9,24-26].
Other studies using culture or species-specific PCRs
have detected A. otitidis (in the absence of recognised
pathogens) in MEF from children with otitis media
collected after careful disinfection of the canal and tym-
panic membrane suggesting infection of the middle
ear [8,27].
In this study, A. otitidis was not detected by PCR in
any nasopharyngeal swabs. Previous PCR and culture-
based studies from other populations have reported A.
otitidis in 7-12% of nasopharyngeal swabs [9,16,23]. As
our study was limited to 27 children, it is possible that
A. otitidis nasopharyngeal carriage may be detected if
a larger cohort were tested. However, failure to detect
A. otitidis in nasopharyngeal swabs from any of the
children with positive ear discharge swabs suggests it is
unlikely to be a primary otopathogen in this population.
This prompts further consideration of A. otitidis in the
canal flora. Staphylococcal sp. were cultured from 10 of
the 11 A. otitidis qPCR-positive ear discharge swabs.
This may indicate detection of canal flora; however,
it was not possible to confirm this as paired canal
swabs were not available. Furthermore, as the study chil-
dren may have had a perforation for up to 6 weeks,
secondary middle ear infection by these species cannot
be excluded.
Bacterial load and relative abundance measures were
used to better understand the significance of A. otitidis in
the polymicrobial ear discharge swabs. A. otitidis bacter-
ial load and relative abundance measures were similar to
that of the otopathogen H. influenzae (in A. otitidis-posi-
tive swabs). For both species, relative abundance <1%
was associated with bacterial load <106 cells/swab and
most of these samples were qPCR-positive and culture-
negative. This suggests a minor role for these species in
these specimens, and may be indicative of canal flora (H.
influenzae has also been reported in normal canal flora
from healthy volunteers [26]). For the remaining speci-
mens, relative abundance ranged from 2-34% and 4-27%
for A. otitidis and H. influenzae, respectively. The signifi-
cance of this finding is unclear as there are no data de-
scribing relative abundance thresholds, and the small size
of this study limits further interpretation. However, a
relative abundance of 34% is clearly suggestive of a dom-
inant species. Furthermore, A. otitidis was present at a
relative abundance greater than that of H. influenzae in
5/10 swabs positive for both species. These data suggest
that, in these children, A. otitidis may have secondarily
infected the middle ear following tympanic membrane
perforation. This interpretation is consistent with the
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who reported substantially higher rates of A. otitidis in
ear canal rather than nasopharyngeal swabs (83% versus
8%) and concluded that A. otitidis in MEF from children
with OME most likely reflected either secondary infec-
tion following perforation or specimen contamination by
canal flora. As Indigenous Australian children are at
high-risk of progressing to CSOM [44], further research
is warranted to better understand A. otitidis in secondary
middle ear infection, particularly where macrolide anti-
biotics, such as azithromycin, are used to treat AOM
with perforation [5].Study limitations
This study retrospectively considered A. otitidis in poly-
microbial ear discharge swabs collected from Indigenous
Australian children with AOM with perforation. The
study specimens had been stored for up to five years.
While it is unclear if prolonged storage may have
adversely affected qPCR detection of A. otitidis, culture-
based studies have reported continued bacterial viability
in upper respiratory swabs after up to 12 years storage
at -70°C [42].
The study focused on Indigenous Australian children
who are at high-risk of progression to CSOM, and thus
the findings may not be generalisable to other popula-
tions. The small study size (27 children) also limits gen-
eralisation of the findings. Despite these limitations, it
appears that A. otitidis is often present in the ear dis-
charge of young Indigenous children with AOM with
perforation (37% of our cohort).
The study was also potentially limited by the ear dis-
charge sampling technique. Ear discharge swabs in this
study were all collected from children with AOM with
perforation affecting <2% of the pars tensa of the tym-
panic membrane for up to six weeks. Paired canal swabs
were not collected. Canals were cleaned prior to sam-
pling, but disinfection was not done. As the small size of
the perforations prevented middle ear sampling, it is
likely that some degree of contamination from canal
flora will be present in the swabs. This limitation pre-
vents definitive differentiation of canal flora from middle
ear pathogens.
The qPCR described in this study is a modification
of a previously published qualitative A. otitidis PCR
[33]. The qPCR had efficiency of 0.87-0.90, slightly
below the ideal range of 0.9-1.10 [45]. This may re-
flect the amplicon size which is approximately twice
that recommended for qPCR [45]. This limitation was
accepted as there are few data describing alternative
A. otitidis-specific PCR targets and a qPCR efficiency
of 0.8-0.9 is common to other bacterial load assays
[46].Conclusions
This study used qPCR to show that A. otitidis is present
in ear discharge swabs from Indigenous Australian chil-
dren with AOM with perforation. In a subset of ear
discharge swabs we found high A. otitidis load and rela-
tive abundance. The absence of A. otitidis in nasopha-
ryngeal swabs suggests A. otitidis may only have a role
in secondary middle ear infection following tympanic
membrane perforation. Larger longitudinal studies and
treatment trials should include paired ear discharge,
canal and nasopharyngeal swabs to further test this
hypothesis. Such studies should be PCR-based and
include culture to assess antibiotic susceptibility. Bacter-
ial load and relative abundance estimates should be con-
sidered when investigating the significance of A. otitidis
in polymicrobial contexts, particularly in children with
existing perforations. In light of the co-detection of
Staphylococcus sp. in 10 of the 11 A. otitidis qPCR-
positive specimens, future studies should also consider
the potential for polymicrobial secondary middle ear in-
fection by these and other species. Where collection of
MEF by tympanocentesis is not feasible, paired ear dis-
charge and canal swabs may be helpful in distinguishing
bacteria from the outer and middle ear. Additional stud-
ies investigating a role for A. otitidis as a secondary
pathogen in CSOM are also warranted in populations
with a high prevalence of spontaneous tympanic mem-
brane perforation.
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